- Price
- $211.77
- Day
- -0.34%
- Mkt Cap
- $148.87B
- 52W Range
- $160.93 – $242.80
- Volume
- 8.78M
- Beta
- 0.81
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Nykredit A S acquired a new position in shares of Danaher Corporation (NYSE: DHR) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 159,476 shares of the conglomerate's stock, valued at approximately $30,377,000. A number of other institutional investors and hedge funds
Read full article
Bank of America Corp DE acquired a new stake in Danaher Corporation (NYSE: DHR) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 5,217,586 shares of the conglomerate's stock, valued at approximately $993,846,000. Bank of America Corp DE owned 0.74% of Danaher
Read full article
WASHINGTON, Sept. 15, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on October 30, 2026 to holders of record on September 30, 2026.
Read full article
Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and Danaher (DHR). But which of these two companies is the best option for those looking for undervalued stocks?
Read full article
Concurrent Investment Advisors LLC lifted its stake in shares of Danaher Corporation (NYSE: DHR) by 29.8% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 11,715 shares of the conglomerate's stock after acquiring an additional 2,691 shares during the period.
Read full article
Continuum Advisory LLC lowered its position in Danaher Corporation (NYSE: DHR) by 87.9% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 481 shares of the conglomerate's stock after selling 3,498 shares during the period. Continuum Advisory LLC's
Read full article
HB Wealth Management LLC cut its position in Danaher Corporation (NYSE: DHR) by 13.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 49,772 shares of the conglomerate's stock after selling 7,499 shares during the period. HB Wealth Management LLC's
Read full article
Healthcare is moving away from the traditional model of mass-produced, one-size-fits-all treatments toward individualized therapies. This evolution in medicine aims to provide treatments that are not only more effective but also carry a lower risk of adverse side effects by aligning with a patient's unique biology.
Read full article